Motor Progression in Early-Stage Parkinson’s Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers.

Motor Progression in Early-Stage Parkinson’s Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers.
Related ArticlesMotor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers. Front Aging Neurosci. 2020;12:627199 Authors: Ma LY, Tian Y, Pan CR, Chen ZL, Ling Y, Ren K, Li JS, Feng T Abstract Background: The substantial heterogeneity of clinical symptoms and lack of reliable progression markers in Parkinson's disease (PD) present a major ... read more
Source: PubMedPublished on 2021-02-12